V-Ensure

V-Ensure Pharma Technologies is a specialty pharmaceutical company based in Mumbai, India, that focuses on the development and manufacturing of complex generic medications. The company specializes in creating value-added formulations for regulated markets, including the United States, European Union, and Canada. Their expertise spans various dosage forms such as oral solids, liquids, and complex injectables, often involving difficult-to-manufacture delivery systems. V-Ensure operates a hybrid business model, acting as both an independent developer of a robust product pipeline and a Contract Development and Manufacturing Organization (CDMO) for international partners. In 2022, the firm received a significant investment from Investcorp to accelerate its growth and expand its manufacturing capabilities.